Locations:
SearchAdvertisement
Genetic variants may help identify which patients could benefit which patients from more aggressive glycemia treatment
Shared decision-making tool published in a recent study fills void
Risks and rewards of supplementation must be carefully weighed for older men with secondary hypogonadism
New study explores intensification inertia in patients with diabetes and above-goal A1C levels
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A pragmatic clinical trial looking at weight loss
In agreement with international group’s recommendations
A closer look at metformin monotherapy
Is there a risk?
Advertisement
Advertisement